The organizations are partnering on a study called the Phenotypes Reimagined to Define Clinical Treatment and Outcome Research study, which will use AI and behavioral health data to predict outcomes like treatment dropout, hospitalizations, and emergency room visits for individuals between the ages of 15 and 30 who are undergoing mental health assessment and treatment for the first time, according to a Sept. 12 news release.
The study will also involve collaboration with researchers from Harvard, Johns Hopkins, Columbia, and Carnegie Mellon universities, as well as Deliberate AI.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
